Pluristem’s Manufacturing Facility Approved by European Auditors for Phase III Trials – Video




Pluristem #39;s Manufacturing Facility Approved by European Auditors for Phase III Trials
HAIFA, Israel, April 28, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (PSTI) (TASE:PLTR) today announced that its new manufacturing facility has received the European Union #39;s Qualified...

By: CorporateProfile

Link:
Pluristem's Manufacturing Facility Approved by European Auditors for Phase III Trials - Video

Related Posts

Comments are closed.